GEA Pharma Systems, unites more than 600 people with a clear pharma engineering passion, providing an advanced one-stop-shop for solid and liquid dosage process equipment for the Pharmaceutical Industry. GEA Pharma Systems is the world leader in advanced solid dose technology and unites the state-of-the-art technologies of Aeromatic™, Buck™, Collette™, Courtoy™, Fielder™, Lyophil™ and Nica™ to combine innovative development and inspired engineering within our entire product range, from individual pieces of equipment to complete process lines.
GEA Pharma Systems’ activities include partnering with customers to develop new products and enhance clinical effectiveness; the supply of R&D-scale and stand-alone production equipment; and the installation of complete integrated production lines.
Innovation - not just for its own sake but for improved products, greater safety and enhanced productivity to deliver a better future.
For GEA Pharma Systems, innovation is the key to our success and to continued prosperity for our customers. In fact it’s more than that. We know that by continually stretching the boundaries of what is possible in pharmaceutical processing we have the ability to support our Customers in enhancing the opportunities available to millions of people all over the world. This is what drives our business.
Our innovation takes many forms and affects all parts of the process. We innovate to increase production and reduce costs, to improve containment and safeguard the workforce, to achieve better clinical effectiveness and to enhance quality control. At GEA Pharma Systems the innovation never stops – it’s just part of what we do.
For example we have pioneered ConsiGma™ Continuous Tablet Production: a unique continuous granulation, drying and tableting process that drastically reduces time to market of new medicines and enables the move to a 6-Sigma process; FlexStream™ (patent pending): our new fluid bed coating system offers multiple processing from a single bowl providing both flexibility and cost benefits. MODUL™ and PERFORMA™ tablet presses combine unrivalled containment with fast product change-over and high productivity. The BuckŪ MC Valve makes the contained handling of active pharmaceutical ingredients much easier and less expensive than has been possible in the past; and PharmaConnect™ which enables diverse GEA development equipment to be docked into a single ‘plug and play’ module with full cGMP compliance.
For more information, please visit http://www.gea-ps.com